卵巢早衰

North American Menopause Society. Early menopause guidebook. 6th edition. Cleveland, OH: North American Menopause Society; 2006.

Chen H, Li J, Cui T, Hu L. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women. Cochrane Database Syst Rev. 2011;(11):CD008018.

• 全文
• 摘要

North American Menopause Society. The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause. 2012;19:257-271.

• 全文
• 摘要

Panzer C, Guay A. Testosterone replacement therapy in naturally and surgically menopausal women. J Sex Med. 2009;6:8-18.

• 摘要

Goodman NF, Cobin RH, Ginzburg SB, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause. Endocr Pract. 2011;17(suppl 6).

• 全文
• 摘要

van Kasteren YM, Schoemaker J. Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update. 1999;5:483-492.

• 摘要

Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med. 2009;360:606-614.

• 摘要

Toulis KA, Tzellos T, Kouvelas D, et al. Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis. Clin Ther. 2009;31:221-235.

• 摘要

1.  North American Menopause Society. Early menopause guidebook. 6th edition. Cleveland, OH: North American Menopause Society; 2006.

2.  Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67:604-606.

• 摘要

3.  Luborsky JL, Meyer P, Sowers MF, et al. Premature menopause in a multi-ethnic population study of the menopause transition. Hum Reprod. 2003;18:199-206.

• 全文
• 摘要

4.  Anasti JN. Premature ovarian failure: an update. Fertil Steril. 1998;70:1-15.

• 摘要

5.  Goswami D, Conway GS. Premature ovarian failure. Hum Reprod Update. 2005;11:391-410.

• 摘要

6.  Shuster LT, Gostout BS, Grossardt BR, et al. Prophylactic oophorectomy in premenopausal women and long-term health - a review. Menopause Int. 2008;14:111-116.

• 全文
• 摘要

7.  European Society of Human Reproduction and Embryology. Management of women with premature ovarian insufficiency. December 2015. https://www.eshre.eu (last accessed 11 March 2016).

• 全文

8.  Cramer DW, Xu H, Harlow BL. Family history as a predictor of early menopause. Fertil Steril. 1995;64:740-745.

• 摘要

9.  Reynaud K, Cortvrindt R, Verlinde F, et al. Number of ovarian follicles in human fetuses with the 45,X karyotype. Fertil Steril. 2004;81:1112-1119.

• 摘要

10.  Hreinsson JG, Otala M, Fridstrom M, et al. Follicles are found in the ovaries of adolescent girls with Turner's syndrome. J Clin Endocrinol Metab. 2002;87:3618-3623.

• 摘要

11.  Partridge AH, Burstein HJ, Winer EP. Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer. J Natl Cancer Inst Monogr. 2001;30:135-142.

• 全文
• 摘要

12.  Oktay K, Sonmezer M. Chemotherapy and amenorrhea: risks and treatment options. Curr Opin Obstet Gynecol. 2008;20:408-415.

• 摘要

13.  Byrne J, Fears TR, Gail MH, et al. Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol. 1992;166:788-793.

• 摘要

14.  Kim TJ, Anasti JN, Flack MR, et al. Routine endocrine screening for patients with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol. 1997;89:777-779.

• 摘要

15.  Belvisi L, Bombelli F, Sironi L, et al. Organ-specific autoimmunity in patients with premature ovarian failure. J Endocrinol Invest. 1993;16:889-892.

• 摘要

16.  Welt CK, Smith PC, Taylor AE. Evidence of early ovarian aging in fragile X premutation carriers. J Clin Endocrinol Metab. 2004;89:4569-4574.

• 摘要

17.  Conway GS, Payne NN, Webb J, et al. Fragile X premutation screening in women with premature ovarian failure. Hum Reprod. 1998;13:1184-1187.

• 全文
• 摘要

18.  Meskhi A, Seif MW. Premature ovarian failure. Curr Opin Obstet Gynecol. 2006;18:418-426.

• 摘要

19.  Siddle N, Sarrel P, Whitehead M. The effect of hysterectomy on the age at ovarian failure: identification of a subgroup of women with premature loss of ovarian function and literature review. Fertil Steril. 1987;47:94-100.

• 摘要

20.  Hascalik S, Celik O, Sarac K, et al. Transient ovarian failure: a rare complication of uterine fibroid embolization. Acta Obstet Gynecol Scand. 2004;83:682-685.

• 摘要

21.  Chang SH, Kim CS, Lee KS, et al. Premenopausal factors influencing premature ovarian failure and early menopause. Maturitas. 2007;58:19-30.

• 摘要

22.  Testa G, Chiaffarino F, Vegetti W, et al. Case-control study on risk factors for premature ovarian failure. Gynecol Obstet Invest. 2001;51:40-43.

• 摘要

23.  Murray A, Bennett CE, Perry JR, et al. Common genetic variants are significant risk factors for early menopause: results from the Breakthrough Generations Study. Hum Mol Genet. 2011;20:186-192.

• 摘要

24.  McKinlay SM. The normal menopause transition: an overview. Maturitas. 1996;23:137-145.

• 摘要

25.  Morice P, Juncker L, Rey A, et al. Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination. Fertil Steril. 2000;74:743-748.

• 摘要

26.  Kim SS, Lee JR, Jee BC, et al. Use of hormonal protection for chemotherapy-induced gonadotoxicity. Clin Obstet Gynecol. 2010;53:740-752.

• 摘要

27.  Chen H, Li J, Cui T, Hu L. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women. Cochrane Database Syst Rev. 2011;(11):CD008018.

• 全文
• 摘要

28.  Del Mastro L, Boni L, Michelotti A, et al. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. JAMA. 2011;306:269-276.

• 摘要

29.  Moore HC, Unger JM, Phillips KA, et al. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med. 2015;372:923-932.

• 全文
• 摘要

30.  Tosh D, Rao KL, Rani HS, et al. Association between fragile X premutation and premature ovarian failure: a case-control study and meta-analysis. Arch Gynecol Obstet. 2014;289:1255-1262.

• 摘要

31.  Perry JR, Corre T, Esko T, et al. A genome-wide association study of early menopause and the combined impact of identified variants. Hum Mol Genet. 2013;22:1465-1472.

• 全文
• 摘要

32.  Ledger WL. Clinical utility of measurement of anti-mullerian hormone in reproductive endocrinology. J Clin Endocrinol Metab. 2010;95:5144-5154.

• 摘要

33.  Kalu E, Panay N. Spontaneous premature ovarian failure: management challenges. Gynecol Endocrinol. 2008;24:273-279.

• 摘要

34.  Bakalov VK, Vanderhoof VH, Bondy CA, et al. Adrenal antibodies detect asymptomatic auto-immune adrenal insufficiency in young women with spontaneous premature ovarian failure. Hum Reprod. 2002;17:2096-2100.

• 全文
• 摘要

35.  Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.

• 摘要

36.  North American Menopause Society. The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause. 2012;19:257-271.

• 全文
• 摘要

37.  Liao KL, Wood N, Conway GS. Premature menopause and psychological well-being. J Psychosom Obstet Gynaecol. 2000;21:167-174.

• 摘要

38.  Kalantaridou SN, Calis KA, Vanderhoof VH, et al. Testosterone deficiency in young women with 46,XX spontaneous premature ovarian failure. Fertil Steril. 2006;86:1475-1482.

• 摘要

39.  Janse F, Tanahatoe SJ, Eijkemans MJ, et al. Testosterone concentrations, using different assays, in different types of ovarian insufficiency: a systematic review and meta-analysis. Hum Reprod Update. 2012;18:405-419.

• 摘要

40.  Panzer C, Guay A. Testosterone replacement therapy in naturally and surgically menopausal women. J Sex Med. 2009;6:8-18.

• 摘要

41.  Shapiro CL, Halabi S, Hars V, et al. Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809. Eur J Cancer. 2011;47:683-689.

• 摘要

42.  Goodman NF, Cobin RH, Ginzburg SB, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause. Endocr Pract. 2011;17(suppl 6).

• 全文
• 摘要

43.  van Kasteren YM, Schoemaker J. Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update. 1999;5:483-492.

• 摘要

44.  Gallagher JC. Effect of early menopause on bone mineral density and fractures. Menopause. 2007;14:567-571.

• 摘要

45.  Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med. 2009;360:606-614.

• 摘要

46.  Toulis KA, Tzellos T, Kouvelas D, et al. Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis. Clin Ther. 2009;31:221-235.

• 摘要

47.  O'Donnell RL, Warner P, Lee RJ, et al. Physiological sex steroid replacement in premature ovarian failure: randomized crossover trial of effect on uterine volume, endometrial thickness and blood flow, compared with a standard regimen. Hum Reprod. 2012;27:1130-1138.

• 全文
• 摘要

48.  Atsma F, Bartelink ML, Grobbee DE, et al. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause. 2006;13:265-279.

• 摘要

49.  Snowdon DA, Kane RL, Beeson WL, et al. Is early natural menopause a biologic marker of health and aging? Am J Public Health. 1989;79:709-714.

• 全文
• 摘要